| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -91.7% |
| R&D Expense | $38.6M | -6.7% |
| SG&A Expense | $16.2M | -6.6% |
| Operating Income | -$53.2M | -21.8% |
| Pre-tax Income | -$53.0M | -21.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$53.0M | -20.0% |
| EPS (Basic) | -$1.49 | -5.7% |
| EPS (Diluted) | -$1.49 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.6M | -19.8% |
| Accounts Receivable | $57K | -98.2% |
| Current Assets | $77.2M | +12.7% |
| Total Assets | $91.3M | +9.5% |
| Current Liabilities | $11.5M | -9.7% |
| Long-term Debt | $8.0M | — |
| Total Liabilities | $25.6M | +43.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.8M | -7.6% |
| Capital Expenditures | $171K | -81.3% |
| Investing Cash Flow | -$24.6M | -370.2% |
| Financing Cash Flow | $53.7M | +179.0% |
| Free Cash Flow | -$42.0M | -5.6% |
| -5.7% |
| Stockholders' Equity |
| $65.7M |
| +0.3% |